nodes	percent_of_prediction	percent_of_DWPC	metapath
Zopiclone—CYP2E1—Fingolimod—multiple sclerosis	0.182	0.307	CbGbCtD
Zopiclone—CYP2E1—Mitoxantrone—multiple sclerosis	0.0858	0.144	CbGbCtD
Zopiclone—CYP3A4—Fingolimod—multiple sclerosis	0.0553	0.0931	CbGbCtD
Zopiclone—CYP2E1—Dexamethasone—multiple sclerosis	0.0445	0.0748	CbGbCtD
Zopiclone—CYP3A4—Methylprednisolone—multiple sclerosis	0.0356	0.06	CbGbCtD
Zopiclone—CYP2C8—Dexamethasone—multiple sclerosis	0.0332	0.0559	CbGbCtD
Zopiclone—CYP3A4—Triamcinolone—multiple sclerosis	0.027	0.0454	CbGbCtD
Zopiclone—CYP3A4—Mitoxantrone—multiple sclerosis	0.026	0.0437	CbGbCtD
Zopiclone—CYP2C9—Dexamethasone—multiple sclerosis	0.0232	0.039	CbGbCtD
Zopiclone—CYP3A4—Betamethasone—multiple sclerosis	0.0232	0.039	CbGbCtD
Zopiclone—CYP3A4—Prednisolone—multiple sclerosis	0.0229	0.0385	CbGbCtD
Zopiclone—CYP3A4—Prednisone—multiple sclerosis	0.0216	0.0363	CbGbCtD
Zopiclone—CYP3A4—Dexamethasone—multiple sclerosis	0.0135	0.0227	CbGbCtD
Zopiclone—GABRB2—brainstem—multiple sclerosis	0.00228	0.0304	CbGeAlD
Zopiclone—GABRA2—brainstem—multiple sclerosis	0.00209	0.0278	CbGeAlD
Zopiclone—GABRG3—nervous system—multiple sclerosis	0.00205	0.0273	CbGeAlD
Zopiclone—GABRA1—brainstem—multiple sclerosis	0.00202	0.0268	CbGeAlD
Zopiclone—GABRG3—central nervous system—multiple sclerosis	0.00197	0.0263	CbGeAlD
Zopiclone—TSPO—brainstem—multiple sclerosis	0.00193	0.0257	CbGeAlD
Zopiclone—TSPO—retina—multiple sclerosis	0.00186	0.0248	CbGeAlD
Zopiclone—GABRG2—medulla oblongata—multiple sclerosis	0.00159	0.0212	CbGeAlD
Zopiclone—GABRB2—medulla oblongata—multiple sclerosis	0.00159	0.0212	CbGeAlD
Zopiclone—GABRA5—nervous system—multiple sclerosis	0.00158	0.021	CbGeAlD
Zopiclone—GABRG3—brain—multiple sclerosis	0.00157	0.0209	CbGeAlD
Zopiclone—GABRA5—central nervous system—multiple sclerosis	0.00152	0.0202	CbGeAlD
Zopiclone—GABRA3—nervous system—multiple sclerosis	0.00147	0.0195	CbGeAlD
Zopiclone—GABRB2—midbrain—multiple sclerosis	0.00146	0.0194	CbGeAlD
Zopiclone—GABRG2—midbrain—multiple sclerosis	0.00146	0.0194	CbGeAlD
Zopiclone—GABRG2—spinal cord—multiple sclerosis	0.00142	0.0189	CbGeAlD
Zopiclone—GABRB2—spinal cord—multiple sclerosis	0.00142	0.0189	CbGeAlD
Zopiclone—GABRA3—central nervous system—multiple sclerosis	0.00141	0.0188	CbGeAlD
Zopiclone—GABRA1—medulla oblongata—multiple sclerosis	0.00141	0.0187	CbGeAlD
Zopiclone—TSPO—medulla oblongata—multiple sclerosis	0.00135	0.0179	CbGeAlD
Zopiclone—GABRA1—midbrain—multiple sclerosis	0.00128	0.0171	CbGeAlD
Zopiclone—GABRA1—spinal cord—multiple sclerosis	0.00125	0.0167	CbGeAlD
Zopiclone—TSPO—midbrain—multiple sclerosis	0.00123	0.0164	CbGeAlD
Zopiclone—GABRB3—medulla oblongata—multiple sclerosis	0.00122	0.0163	CbGeAlD
Zopiclone—GABRA5—brain—multiple sclerosis	0.0012	0.016	CbGeAlD
Zopiclone—TSPO—spinal cord—multiple sclerosis	0.0012	0.016	CbGeAlD
Zopiclone—GABRG2—nervous system—multiple sclerosis	0.0012	0.0159	CbGeAlD
Zopiclone—GABRB2—nervous system—multiple sclerosis	0.0012	0.0159	CbGeAlD
Zopiclone—GABRG2—central nervous system—multiple sclerosis	0.00115	0.0153	CbGeAlD
Zopiclone—GABRB2—central nervous system—multiple sclerosis	0.00115	0.0153	CbGeAlD
Zopiclone—GABRG2—cerebellum—multiple sclerosis	0.00113	0.015	CbGeAlD
Zopiclone—GABRB2—cerebellum—multiple sclerosis	0.00113	0.015	CbGeAlD
Zopiclone—GABRA3—brain—multiple sclerosis	0.00112	0.0149	CbGeAlD
Zopiclone—GABRB3—midbrain—multiple sclerosis	0.00112	0.0149	CbGeAlD
Zopiclone—GABRA2—nervous system—multiple sclerosis	0.00109	0.0145	CbGeAlD
Zopiclone—GABRB3—spinal cord—multiple sclerosis	0.00109	0.0145	CbGeAlD
Zopiclone—GABRA1—nervous system—multiple sclerosis	0.00106	0.0141	CbGeAlD
Zopiclone—GABRA2—central nervous system—multiple sclerosis	0.00105	0.014	CbGeAlD
Zopiclone—GABRA2—cerebellum—multiple sclerosis	0.00103	0.0137	CbGeAlD
Zopiclone—GABRA1—central nervous system—multiple sclerosis	0.00102	0.0135	CbGeAlD
Zopiclone—TSPO—nervous system—multiple sclerosis	0.00101	0.0135	CbGeAlD
Zopiclone—GABRA1—cerebellum—multiple sclerosis	0.000994	0.0132	CbGeAlD
Zopiclone—TSPO—central nervous system—multiple sclerosis	0.000974	0.013	CbGeAlD
Zopiclone—TSPO—cerebellum—multiple sclerosis	0.000952	0.0127	CbGeAlD
Zopiclone—GABRB3—nervous system—multiple sclerosis	0.000919	0.0122	CbGeAlD
Zopiclone—GABRG2—brain—multiple sclerosis	0.000914	0.0122	CbGeAlD
Zopiclone—GABRB2—brain—multiple sclerosis	0.000914	0.0122	CbGeAlD
Zopiclone—GABRB3—central nervous system—multiple sclerosis	0.000884	0.0118	CbGeAlD
Zopiclone—GABRB3—cerebellum—multiple sclerosis	0.000864	0.0115	CbGeAlD
Zopiclone—GABRA2—brain—multiple sclerosis	0.000835	0.0111	CbGeAlD
Zopiclone—GABRA1—brain—multiple sclerosis	0.000807	0.0107	CbGeAlD
Zopiclone—CYP2E1—medulla oblongata—multiple sclerosis	0.000778	0.0103	CbGeAlD
Zopiclone—TSPO—brain—multiple sclerosis	0.000773	0.0103	CbGeAlD
Zopiclone—GABRB3—brain—multiple sclerosis	0.000702	0.00934	CbGeAlD
Zopiclone—CYP2E1—spinal cord—multiple sclerosis	0.000694	0.00923	CbGeAlD
Zopiclone—PTGS1—spinal cord—multiple sclerosis	0.000668	0.00889	CbGeAlD
Zopiclone—CYP2E1—nervous system—multiple sclerosis	0.000584	0.00778	CbGeAlD
Zopiclone—PTGS1—nervous system—multiple sclerosis	0.000563	0.00749	CbGeAlD
Zopiclone—CYP2E1—central nervous system—multiple sclerosis	0.000563	0.00749	CbGeAlD
Zopiclone—CYP2E1—cerebellum—multiple sclerosis	0.00055	0.00732	CbGeAlD
Zopiclone—PTGS1—central nervous system—multiple sclerosis	0.000542	0.00721	CbGeAlD
Zopiclone—CYP2C8—brain—multiple sclerosis	0.000531	0.00706	CbGeAlD
Zopiclone—CYP3A4—nervous system—multiple sclerosis	0.00047	0.00626	CbGeAlD
Zopiclone—CYP3A4—central nervous system—multiple sclerosis	0.000453	0.00602	CbGeAlD
Zopiclone—CYP2E1—brain—multiple sclerosis	0.000447	0.00594	CbGeAlD
Zopiclone—PTGS1—brain—multiple sclerosis	0.00043	0.00573	CbGeAlD
Zopiclone—Convulsion—Methylprednisolone—multiple sclerosis	0.000298	0.000905	CcSEcCtD
Zopiclone—Hypertension—Triamcinolone—multiple sclerosis	0.000297	0.000904	CcSEcCtD
Zopiclone—Hypertension—Methylprednisolone—multiple sclerosis	0.000297	0.000902	CcSEcCtD
Zopiclone—Urticaria—Mitoxantrone—multiple sclerosis	0.000296	0.0009	CcSEcCtD
Zopiclone—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000295	0.000899	CcSEcCtD
Zopiclone—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000294	0.000896	CcSEcCtD
Zopiclone—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000294	0.000896	CcSEcCtD
Zopiclone—Myalgia—Triamcinolone—multiple sclerosis	0.000293	0.000892	CcSEcCtD
Zopiclone—Vomiting—Azathioprine—multiple sclerosis	0.000293	0.000891	CcSEcCtD
Zopiclone—Myalgia—Methylprednisolone—multiple sclerosis	0.000292	0.00089	CcSEcCtD
Zopiclone—Anxiety—Methylprednisolone—multiple sclerosis	0.000291	0.000887	CcSEcCtD
Zopiclone—Drowsiness—Methotrexate—multiple sclerosis	0.000291	0.000885	CcSEcCtD
Zopiclone—Rash—Azathioprine—multiple sclerosis	0.00029	0.000884	CcSEcCtD
Zopiclone—Dermatitis—Azathioprine—multiple sclerosis	0.00029	0.000883	CcSEcCtD
Zopiclone—Depression—Methotrexate—multiple sclerosis	0.00029	0.000883	CcSEcCtD
Zopiclone—Ill-defined disorder—Betamethasone—multiple sclerosis	0.00029	0.000882	CcSEcCtD
Zopiclone—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.00029	0.000882	CcSEcCtD
Zopiclone—Discomfort—Triamcinolone—multiple sclerosis	0.00029	0.000881	CcSEcCtD
Zopiclone—Discomfort—Methylprednisolone—multiple sclerosis	0.000289	0.000879	CcSEcCtD
Zopiclone—Headache—Azathioprine—multiple sclerosis	0.000289	0.000878	CcSEcCtD
Zopiclone—Dry mouth—Triamcinolone—multiple sclerosis	0.000287	0.000872	CcSEcCtD
Zopiclone—Angioedema—Betamethasone—multiple sclerosis	0.000285	0.000868	CcSEcCtD
Zopiclone—Angioedema—Dexamethasone—multiple sclerosis	0.000285	0.000868	CcSEcCtD
Zopiclone—Stomatitis—Methotrexate—multiple sclerosis	0.000284	0.000863	CcSEcCtD
Zopiclone—Conjunctivitis—Methotrexate—multiple sclerosis	0.000283	0.00086	CcSEcCtD
Zopiclone—Confusional state—Methylprednisolone—multiple sclerosis	0.000283	0.00086	CcSEcCtD
Zopiclone—Malaise—Betamethasone—multiple sclerosis	0.000282	0.000857	CcSEcCtD
Zopiclone—Malaise—Dexamethasone—multiple sclerosis	0.000282	0.000857	CcSEcCtD
Zopiclone—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000281	0.000855	CcSEcCtD
Zopiclone—Vertigo—Dexamethasone—multiple sclerosis	0.000281	0.000854	CcSEcCtD
Zopiclone—Vertigo—Betamethasone—multiple sclerosis	0.000281	0.000854	CcSEcCtD
Zopiclone—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.00028	0.000853	CcSEcCtD
Zopiclone—Infection—Triamcinolone—multiple sclerosis	0.000279	0.000849	CcSEcCtD
Zopiclone—Sweating—Methotrexate—multiple sclerosis	0.000279	0.000849	CcSEcCtD
Zopiclone—Infection—Methylprednisolone—multiple sclerosis	0.000278	0.000847	CcSEcCtD
Zopiclone—Haematuria—Methotrexate—multiple sclerosis	0.000277	0.000844	CcSEcCtD
Zopiclone—Insomnia—Prednisolone—multiple sclerosis	0.000276	0.000841	CcSEcCtD
Zopiclone—Alopecia—Prednisone—multiple sclerosis	0.000276	0.00084	CcSEcCtD
Zopiclone—Epistaxis—Methotrexate—multiple sclerosis	0.000274	0.000835	CcSEcCtD
Zopiclone—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000274	0.000835	CcSEcCtD
Zopiclone—Paraesthesia—Prednisolone—multiple sclerosis	0.000274	0.000835	CcSEcCtD
Zopiclone—Tachycardia—Triamcinolone—multiple sclerosis	0.000274	0.000834	CcSEcCtD
Zopiclone—Nausea—Azathioprine—multiple sclerosis	0.000274	0.000833	CcSEcCtD
Zopiclone—Tachycardia—Methylprednisolone—multiple sclerosis	0.000274	0.000832	CcSEcCtD
Zopiclone—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000272	0.000826	CcSEcCtD
Zopiclone—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000271	0.000825	CcSEcCtD
Zopiclone—Convulsion—Betamethasone—multiple sclerosis	0.000271	0.000823	CcSEcCtD
Zopiclone—Convulsion—Dexamethasone—multiple sclerosis	0.000271	0.000823	CcSEcCtD
Zopiclone—Hypertension—Dexamethasone—multiple sclerosis	0.00027	0.000821	CcSEcCtD
Zopiclone—Hypertension—Betamethasone—multiple sclerosis	0.00027	0.000821	CcSEcCtD
Zopiclone—Asthenia—Mitoxantrone—multiple sclerosis	0.000267	0.000813	CcSEcCtD
Zopiclone—Myalgia—Dexamethasone—multiple sclerosis	0.000266	0.000809	CcSEcCtD
Zopiclone—Myalgia—Betamethasone—multiple sclerosis	0.000266	0.000809	CcSEcCtD
Zopiclone—Anxiety—Dexamethasone—multiple sclerosis	0.000265	0.000806	CcSEcCtD
Zopiclone—Anxiety—Betamethasone—multiple sclerosis	0.000265	0.000806	CcSEcCtD
Zopiclone—Discomfort—Betamethasone—multiple sclerosis	0.000263	0.000799	CcSEcCtD
Zopiclone—Discomfort—Dexamethasone—multiple sclerosis	0.000263	0.000799	CcSEcCtD
Zopiclone—Pain—Prednisolone—multiple sclerosis	0.000261	0.000795	CcSEcCtD
Zopiclone—Hepatitis—Methotrexate—multiple sclerosis	0.000261	0.000795	CcSEcCtD
Zopiclone—Pharyngitis—Methotrexate—multiple sclerosis	0.000259	0.000789	CcSEcCtD
Zopiclone—Vision blurred—Prednisone—multiple sclerosis	0.000256	0.00078	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000256	0.000779	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000255	0.000777	CcSEcCtD
Zopiclone—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000255	0.000776	CcSEcCtD
Zopiclone—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000255	0.000776	CcSEcCtD
Zopiclone—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000255	0.000775	CcSEcCtD
Zopiclone—Insomnia—Triamcinolone—multiple sclerosis	0.000254	0.000773	CcSEcCtD
Zopiclone—Insomnia—Methylprednisolone—multiple sclerosis	0.000254	0.000771	CcSEcCtD
Zopiclone—Infection—Dexamethasone—multiple sclerosis	0.000253	0.000771	CcSEcCtD
Zopiclone—Infection—Betamethasone—multiple sclerosis	0.000253	0.000771	CcSEcCtD
Zopiclone—Ill-defined disorder—Prednisone—multiple sclerosis	0.000252	0.000768	CcSEcCtD
Zopiclone—Paraesthesia—Triamcinolone—multiple sclerosis	0.000252	0.000768	CcSEcCtD
Zopiclone—Feeling abnormal—Prednisolone—multiple sclerosis	0.000252	0.000766	CcSEcCtD
Zopiclone—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000252	0.000766	CcSEcCtD
Zopiclone—Anaemia—Prednisone—multiple sclerosis	0.000251	0.000765	CcSEcCtD
Zopiclone—Dyspnoea—Triamcinolone—multiple sclerosis	0.00025	0.000762	CcSEcCtD
Zopiclone—Agitation—Prednisone—multiple sclerosis	0.00025	0.000761	CcSEcCtD
Zopiclone—Tachycardia—Dexamethasone—multiple sclerosis	0.000249	0.000757	CcSEcCtD
Zopiclone—Tachycardia—Betamethasone—multiple sclerosis	0.000249	0.000757	CcSEcCtD
Zopiclone—Angioedema—Prednisone—multiple sclerosis	0.000249	0.000756	CcSEcCtD
Zopiclone—Dyspepsia—Triamcinolone—multiple sclerosis	0.000247	0.000752	CcSEcCtD
Zopiclone—Erythema multiforme—Methotrexate—multiple sclerosis	0.000247	0.000751	CcSEcCtD
Zopiclone—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000247	0.000751	CcSEcCtD
Zopiclone—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000246	0.00075	CcSEcCtD
Zopiclone—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000246	0.00075	CcSEcCtD
Zopiclone—Malaise—Prednisone—multiple sclerosis	0.000245	0.000746	CcSEcCtD
Zopiclone—Vertigo—Prednisone—multiple sclerosis	0.000244	0.000744	CcSEcCtD
Zopiclone—Tinnitus—Methotrexate—multiple sclerosis	0.000243	0.000741	CcSEcCtD
Zopiclone—Anorexia—Betamethasone—multiple sclerosis	0.000243	0.000739	CcSEcCtD
Zopiclone—Anorexia—Dexamethasone—multiple sclerosis	0.000243	0.000739	CcSEcCtD
Zopiclone—Urticaria—Prednisolone—multiple sclerosis	0.000243	0.000738	CcSEcCtD
Zopiclone—Fatigue—Triamcinolone—multiple sclerosis	0.000242	0.000737	CcSEcCtD
Zopiclone—Fatigue—Methylprednisolone—multiple sclerosis	0.000242	0.000735	CcSEcCtD
Zopiclone—Pain—Triamcinolone—multiple sclerosis	0.00024	0.000731	CcSEcCtD
Zopiclone—Vomiting—Mitoxantrone—multiple sclerosis	0.000237	0.00072	CcSEcCtD
Zopiclone—Convulsion—Prednisone—multiple sclerosis	0.000236	0.000717	CcSEcCtD
Zopiclone—Hypertension—Prednisone—multiple sclerosis	0.000235	0.000715	CcSEcCtD
Zopiclone—Rash—Mitoxantrone—multiple sclerosis	0.000235	0.000714	CcSEcCtD
Zopiclone—Dermatitis—Mitoxantrone—multiple sclerosis	0.000235	0.000714	CcSEcCtD
Zopiclone—Chills—Methotrexate—multiple sclerosis	0.000234	0.000713	CcSEcCtD
Zopiclone—Headache—Mitoxantrone—multiple sclerosis	0.000233	0.00071	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000232	0.000707	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000232	0.000707	CcSEcCtD
Zopiclone—Myalgia—Prednisone—multiple sclerosis	0.000232	0.000705	CcSEcCtD
Zopiclone—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000232	0.000704	CcSEcCtD
Zopiclone—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000231	0.000703	CcSEcCtD
Zopiclone—Anxiety—Prednisone—multiple sclerosis	0.000231	0.000702	CcSEcCtD
Zopiclone—Alopecia—Methotrexate—multiple sclerosis	0.000231	0.000702	CcSEcCtD
Zopiclone—Insomnia—Dexamethasone—multiple sclerosis	0.000231	0.000702	CcSEcCtD
Zopiclone—Insomnia—Betamethasone—multiple sclerosis	0.000231	0.000702	CcSEcCtD
Zopiclone—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000229	0.000697	CcSEcCtD
Zopiclone—Paraesthesia—Dexamethasone—multiple sclerosis	0.000229	0.000696	CcSEcCtD
Zopiclone—Paraesthesia—Betamethasone—multiple sclerosis	0.000229	0.000696	CcSEcCtD
Zopiclone—Discomfort—Prednisone—multiple sclerosis	0.000229	0.000696	CcSEcCtD
Zopiclone—Hypersensitivity—Prednisolone—multiple sclerosis	0.000225	0.000685	CcSEcCtD
Zopiclone—Dyspepsia—Betamethasone—multiple sclerosis	0.000224	0.000683	CcSEcCtD
Zopiclone—Dyspepsia—Dexamethasone—multiple sclerosis	0.000224	0.000683	CcSEcCtD
Zopiclone—Urticaria—Triamcinolone—multiple sclerosis	0.000223	0.000679	CcSEcCtD
Zopiclone—Urticaria—Methylprednisolone—multiple sclerosis	0.000223	0.000678	CcSEcCtD
Zopiclone—Dysgeusia—Methotrexate—multiple sclerosis	0.000223	0.000677	CcSEcCtD
Zopiclone—Body temperature increased—Triamcinolone—multiple sclerosis	0.000222	0.000676	CcSEcCtD
Zopiclone—Anaphylactic shock—Prednisone—multiple sclerosis	0.000222	0.000675	CcSEcCtD
Zopiclone—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000222	0.000674	CcSEcCtD
Zopiclone—Decreased appetite—Dexamethasone—multiple sclerosis	0.000222	0.000674	CcSEcCtD
Zopiclone—Decreased appetite—Betamethasone—multiple sclerosis	0.000222	0.000674	CcSEcCtD
Zopiclone—Nausea—Mitoxantrone—multiple sclerosis	0.000221	0.000673	CcSEcCtD
Zopiclone—Infection—Prednisone—multiple sclerosis	0.000221	0.000671	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.00022	0.00067	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.00022	0.00067	CcSEcCtD
Zopiclone—Back pain—Methotrexate—multiple sclerosis	0.00022	0.000669	CcSEcCtD
Zopiclone—Fatigue—Betamethasone—multiple sclerosis	0.00022	0.000669	CcSEcCtD
Zopiclone—Fatigue—Dexamethasone—multiple sclerosis	0.00022	0.000669	CcSEcCtD
Zopiclone—Pain—Betamethasone—multiple sclerosis	0.000218	0.000663	CcSEcCtD
Zopiclone—Pain—Dexamethasone—multiple sclerosis	0.000218	0.000663	CcSEcCtD
Zopiclone—Tachycardia—Prednisone—multiple sclerosis	0.000217	0.000659	CcSEcCtD
Zopiclone—Hyperhidrosis—Prednisone—multiple sclerosis	0.000215	0.000653	CcSEcCtD
Zopiclone—Vision blurred—Methotrexate—multiple sclerosis	0.000214	0.000652	CcSEcCtD
Zopiclone—Anorexia—Prednisone—multiple sclerosis	0.000212	0.000644	CcSEcCtD
Zopiclone—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000211	0.000642	CcSEcCtD
Zopiclone—Anaemia—Methotrexate—multiple sclerosis	0.00021	0.000639	CcSEcCtD
Zopiclone—Feeling abnormal—Dexamethasone—multiple sclerosis	0.00021	0.000639	CcSEcCtD
Zopiclone—Feeling abnormal—Betamethasone—multiple sclerosis	0.00021	0.000639	CcSEcCtD
Zopiclone—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000208	0.000634	CcSEcCtD
Zopiclone—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000208	0.000634	CcSEcCtD
Zopiclone—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000207	0.00063	CcSEcCtD
Zopiclone—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000207	0.000628	CcSEcCtD
Zopiclone—Malaise—Methotrexate—multiple sclerosis	0.000205	0.000624	CcSEcCtD
Zopiclone—Vertigo—Methotrexate—multiple sclerosis	0.000204	0.000621	CcSEcCtD
Zopiclone—Urticaria—Dexamethasone—multiple sclerosis	0.000203	0.000616	CcSEcCtD
Zopiclone—Urticaria—Betamethasone—multiple sclerosis	0.000203	0.000616	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000202	0.000615	CcSEcCtD
Zopiclone—Dizziness—Prednisolone—multiple sclerosis	0.000202	0.000615	CcSEcCtD
Zopiclone—Asthenia—Triamcinolone—multiple sclerosis	0.000202	0.000613	CcSEcCtD
Zopiclone—Abdominal pain—Betamethasone—multiple sclerosis	0.000202	0.000613	CcSEcCtD
Zopiclone—Abdominal pain—Dexamethasone—multiple sclerosis	0.000202	0.000613	CcSEcCtD
Zopiclone—Body temperature increased—Dexamethasone—multiple sclerosis	0.000202	0.000613	CcSEcCtD
Zopiclone—Body temperature increased—Betamethasone—multiple sclerosis	0.000202	0.000613	CcSEcCtD
Zopiclone—Asthenia—Methylprednisolone—multiple sclerosis	0.000201	0.000612	CcSEcCtD
Zopiclone—Insomnia—Prednisone—multiple sclerosis	0.000201	0.000611	CcSEcCtD
Zopiclone—Paraesthesia—Prednisone—multiple sclerosis	0.000199	0.000607	CcSEcCtD
Zopiclone—Pruritus—Triamcinolone—multiple sclerosis	0.000199	0.000605	CcSEcCtD
Zopiclone—Pruritus—Methylprednisolone—multiple sclerosis	0.000198	0.000603	CcSEcCtD
Zopiclone—Convulsion—Methotrexate—multiple sclerosis	0.000197	0.000599	CcSEcCtD
Zopiclone—Dyspepsia—Prednisone—multiple sclerosis	0.000195	0.000595	CcSEcCtD
Zopiclone—Chest pain—Methotrexate—multiple sclerosis	0.000194	0.000589	CcSEcCtD
Zopiclone—Myalgia—Methotrexate—multiple sclerosis	0.000194	0.000589	CcSEcCtD
Zopiclone—Decreased appetite—Prednisone—multiple sclerosis	0.000193	0.000587	CcSEcCtD
Zopiclone—Rash—Prednisolone—multiple sclerosis	0.000193	0.000586	CcSEcCtD
Zopiclone—Dermatitis—Prednisolone—multiple sclerosis	0.000192	0.000586	CcSEcCtD
Zopiclone—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000192	0.000584	CcSEcCtD
Zopiclone—Fatigue—Prednisone—multiple sclerosis	0.000191	0.000582	CcSEcCtD
Zopiclone—Headache—Prednisolone—multiple sclerosis	0.000191	0.000582	CcSEcCtD
Zopiclone—Discomfort—Methotrexate—multiple sclerosis	0.000191	0.000582	CcSEcCtD
Zopiclone—Constipation—Prednisone—multiple sclerosis	0.00019	0.000578	CcSEcCtD
Zopiclone—Confusional state—Methotrexate—multiple sclerosis	0.000187	0.000569	CcSEcCtD
Zopiclone—Dizziness—Triamcinolone—multiple sclerosis	0.000186	0.000565	CcSEcCtD
Zopiclone—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000186	0.000565	CcSEcCtD
Zopiclone—Dizziness—Methylprednisolone—multiple sclerosis	0.000185	0.000564	CcSEcCtD
Zopiclone—Infection—Methotrexate—multiple sclerosis	0.000184	0.000561	CcSEcCtD
Zopiclone—Feeling abnormal—Prednisone—multiple sclerosis	0.000183	0.000557	CcSEcCtD
Zopiclone—Asthenia—Betamethasone—multiple sclerosis	0.000183	0.000556	CcSEcCtD
Zopiclone—Asthenia—Dexamethasone—multiple sclerosis	0.000183	0.000556	CcSEcCtD
Zopiclone—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000182	0.000552	CcSEcCtD
Zopiclone—Nausea—Prednisolone—multiple sclerosis	0.000181	0.000552	CcSEcCtD
Zopiclone—Pruritus—Dexamethasone—multiple sclerosis	0.00018	0.000549	CcSEcCtD
Zopiclone—Pruritus—Betamethasone—multiple sclerosis	0.00018	0.000549	CcSEcCtD
Zopiclone—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000179	0.000546	CcSEcCtD
Zopiclone—Vomiting—Triamcinolone—multiple sclerosis	0.000179	0.000544	CcSEcCtD
Zopiclone—Vomiting—Methylprednisolone—multiple sclerosis	0.000178	0.000542	CcSEcCtD
Zopiclone—Rash—Triamcinolone—multiple sclerosis	0.000177	0.000539	CcSEcCtD
Zopiclone—Dermatitis—Triamcinolone—multiple sclerosis	0.000177	0.000538	CcSEcCtD
Zopiclone—Anorexia—Methotrexate—multiple sclerosis	0.000177	0.000538	CcSEcCtD
Zopiclone—Rash—Methylprednisolone—multiple sclerosis	0.000177	0.000538	CcSEcCtD
Zopiclone—Dermatitis—Methylprednisolone—multiple sclerosis	0.000177	0.000537	CcSEcCtD
Zopiclone—Urticaria—Prednisone—multiple sclerosis	0.000176	0.000537	CcSEcCtD
Zopiclone—Headache—Triamcinolone—multiple sclerosis	0.000176	0.000536	CcSEcCtD
Zopiclone—Headache—Methylprednisolone—multiple sclerosis	0.000176	0.000534	CcSEcCtD
Zopiclone—Abdominal pain—Prednisone—multiple sclerosis	0.000175	0.000534	CcSEcCtD
Zopiclone—Body temperature increased—Prednisone—multiple sclerosis	0.000175	0.000534	CcSEcCtD
Zopiclone—Diarrhoea—Dexamethasone—multiple sclerosis	0.000174	0.000531	CcSEcCtD
Zopiclone—Diarrhoea—Betamethasone—multiple sclerosis	0.000174	0.000531	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000169	0.000514	CcSEcCtD
Zopiclone—Dizziness—Betamethasone—multiple sclerosis	0.000169	0.000513	CcSEcCtD
Zopiclone—Dizziness—Dexamethasone—multiple sclerosis	0.000169	0.000513	CcSEcCtD
Zopiclone—Insomnia—Methotrexate—multiple sclerosis	0.000168	0.000511	CcSEcCtD
Zopiclone—Nausea—Triamcinolone—multiple sclerosis	0.000167	0.000508	CcSEcCtD
Zopiclone—Paraesthesia—Methotrexate—multiple sclerosis	0.000167	0.000507	CcSEcCtD
Zopiclone—Nausea—Methylprednisolone—multiple sclerosis	0.000167	0.000507	CcSEcCtD
Zopiclone—Dyspnoea—Methotrexate—multiple sclerosis	0.000165	0.000503	CcSEcCtD
Zopiclone—Somnolence—Methotrexate—multiple sclerosis	0.000165	0.000502	CcSEcCtD
Zopiclone—Hypersensitivity—Prednisone—multiple sclerosis	0.000164	0.000498	CcSEcCtD
Zopiclone—Dyspepsia—Methotrexate—multiple sclerosis	0.000163	0.000497	CcSEcCtD
Zopiclone—Vomiting—Dexamethasone—multiple sclerosis	0.000162	0.000493	CcSEcCtD
Zopiclone—Vomiting—Betamethasone—multiple sclerosis	0.000162	0.000493	CcSEcCtD
Zopiclone—Decreased appetite—Methotrexate—multiple sclerosis	0.000161	0.000491	CcSEcCtD
Zopiclone—Rash—Betamethasone—multiple sclerosis	0.000161	0.000489	CcSEcCtD
Zopiclone—Rash—Dexamethasone—multiple sclerosis	0.000161	0.000489	CcSEcCtD
Zopiclone—Dermatitis—Dexamethasone—multiple sclerosis	0.000161	0.000489	CcSEcCtD
Zopiclone—Dermatitis—Betamethasone—multiple sclerosis	0.000161	0.000489	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.00016	0.000487	CcSEcCtD
Zopiclone—Fatigue—Methotrexate—multiple sclerosis	0.00016	0.000487	CcSEcCtD
Zopiclone—Headache—Betamethasone—multiple sclerosis	0.00016	0.000486	CcSEcCtD
Zopiclone—Headache—Dexamethasone—multiple sclerosis	0.00016	0.000486	CcSEcCtD
Zopiclone—Asthenia—Prednisone—multiple sclerosis	0.000159	0.000485	CcSEcCtD
Zopiclone—Pain—Methotrexate—multiple sclerosis	0.000159	0.000483	CcSEcCtD
Zopiclone—Pruritus—Prednisone—multiple sclerosis	0.000157	0.000478	CcSEcCtD
Zopiclone—Feeling abnormal—Methotrexate—multiple sclerosis	0.000153	0.000465	CcSEcCtD
Zopiclone—Diarrhoea—Prednisone—multiple sclerosis	0.000152	0.000462	CcSEcCtD
Zopiclone—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000152	0.000462	CcSEcCtD
Zopiclone—Nausea—Dexamethasone—multiple sclerosis	0.000151	0.000461	CcSEcCtD
Zopiclone—Nausea—Betamethasone—multiple sclerosis	0.000151	0.000461	CcSEcCtD
Zopiclone—Urticaria—Methotrexate—multiple sclerosis	0.000147	0.000448	CcSEcCtD
Zopiclone—Dizziness—Prednisone—multiple sclerosis	0.000147	0.000447	CcSEcCtD
Zopiclone—Abdominal pain—Methotrexate—multiple sclerosis	0.000147	0.000446	CcSEcCtD
Zopiclone—Body temperature increased—Methotrexate—multiple sclerosis	0.000147	0.000446	CcSEcCtD
Zopiclone—Vomiting—Prednisone—multiple sclerosis	0.000141	0.000429	CcSEcCtD
Zopiclone—Rash—Prednisone—multiple sclerosis	0.00014	0.000426	CcSEcCtD
Zopiclone—Dermatitis—Prednisone—multiple sclerosis	0.00014	0.000426	CcSEcCtD
Zopiclone—Headache—Prednisone—multiple sclerosis	0.000139	0.000423	CcSEcCtD
Zopiclone—Hypersensitivity—Methotrexate—multiple sclerosis	0.000137	0.000416	CcSEcCtD
Zopiclone—Asthenia—Methotrexate—multiple sclerosis	0.000133	0.000405	CcSEcCtD
Zopiclone—Nausea—Prednisone—multiple sclerosis	0.000132	0.000401	CcSEcCtD
Zopiclone—Pruritus—Methotrexate—multiple sclerosis	0.000131	0.000399	CcSEcCtD
Zopiclone—Diarrhoea—Methotrexate—multiple sclerosis	0.000127	0.000386	CcSEcCtD
Zopiclone—Dizziness—Methotrexate—multiple sclerosis	0.000123	0.000373	CcSEcCtD
Zopiclone—Vomiting—Methotrexate—multiple sclerosis	0.000118	0.000359	CcSEcCtD
Zopiclone—Rash—Methotrexate—multiple sclerosis	0.000117	0.000356	CcSEcCtD
Zopiclone—Dermatitis—Methotrexate—multiple sclerosis	0.000117	0.000356	CcSEcCtD
Zopiclone—Headache—Methotrexate—multiple sclerosis	0.000116	0.000354	CcSEcCtD
Zopiclone—Nausea—Methotrexate—multiple sclerosis	0.00011	0.000335	CcSEcCtD
Zopiclone—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	4.57e-05	0.0224	CbGpPWpGaD
Zopiclone—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	4.57e-05	0.0224	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	4.15e-05	0.0203	CbGpPWpGaD
Zopiclone—GABRB3—BDNF signaling pathway—KCNA3—multiple sclerosis	3.91e-05	0.0191	CbGpPWpGaD
Zopiclone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	3.21e-05	0.0157	CbGpPWpGaD
Zopiclone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	3.21e-05	0.0157	CbGpPWpGaD
Zopiclone—PTGS1—Prostaglandin Synthesis and Regulation—PTGER4—multiple sclerosis	3.21e-05	0.0157	CbGpPWpGaD
Zopiclone—PTGS1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	3.15e-05	0.0154	CbGpPWpGaD
Zopiclone—PTGS1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	3.15e-05	0.0154	CbGpPWpGaD
Zopiclone—GABRB3—BDNF signaling pathway—LINGO1—multiple sclerosis	3.12e-05	0.0153	CbGpPWpGaD
Zopiclone—GABRG3—Neuronal System—KCNA3—multiple sclerosis	2.94e-05	0.0144	CbGpPWpGaD
Zopiclone—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	2.9e-05	0.0142	CbGpPWpGaD
Zopiclone—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	2.9e-05	0.0142	CbGpPWpGaD
Zopiclone—CYP2E1—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	2.86e-05	0.014	CbGpPWpGaD
Zopiclone—CYP2E1—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	2.86e-05	0.014	CbGpPWpGaD
Zopiclone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	2.51e-05	0.0123	CbGpPWpGaD
Zopiclone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	2.51e-05	0.0123	CbGpPWpGaD
Zopiclone—CYP2C8—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	2.47e-05	0.0121	CbGpPWpGaD
Zopiclone—CYP2C8—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	2.47e-05	0.0121	CbGpPWpGaD
Zopiclone—GABRB2—Neuronal System—KCNA3—multiple sclerosis	2.47e-05	0.0121	CbGpPWpGaD
Zopiclone—GABRA5—Neuronal System—KCNA3—multiple sclerosis	2.4e-05	0.0118	CbGpPWpGaD
Zopiclone—GABRA3—Neuronal System—KCNA3—multiple sclerosis	2.36e-05	0.0116	CbGpPWpGaD
Zopiclone—CYP2E1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	2.35e-05	0.0115	CbGpPWpGaD
Zopiclone—CYP2E1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	2.35e-05	0.0115	CbGpPWpGaD
Zopiclone—GABRA2—Neuronal System—KCNA3—multiple sclerosis	2.32e-05	0.0114	CbGpPWpGaD
Zopiclone—GABRB3—Neuronal System—KCNA3—multiple sclerosis	2.3e-05	0.0113	CbGpPWpGaD
Zopiclone—GABRG2—Neuronal System—KCNA3—multiple sclerosis	2.26e-05	0.0111	CbGpPWpGaD
Zopiclone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	2.12e-05	0.0104	CbGpPWpGaD
Zopiclone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	2.12e-05	0.0104	CbGpPWpGaD
Zopiclone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	2.04e-05	0.01	CbGpPWpGaD
Zopiclone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	2.04e-05	0.01	CbGpPWpGaD
Zopiclone—CYP2C8—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	2.03e-05	0.00996	CbGpPWpGaD
Zopiclone—CYP2C8—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	2.03e-05	0.00996	CbGpPWpGaD
Zopiclone—CYP2C9—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	2.01e-05	0.00987	CbGpPWpGaD
Zopiclone—CYP2C9—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	2.01e-05	0.00987	CbGpPWpGaD
Zopiclone—GABRA1—Neuronal System—KCNA3—multiple sclerosis	1.98e-05	0.00968	CbGpPWpGaD
Zopiclone—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	1.88e-05	0.00919	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—C4A—multiple sclerosis	1.72e-05	0.00845	CbGpPWpGaD
Zopiclone—PTGS1—Biological oxidations—CYP27B1—multiple sclerosis	1.67e-05	0.00819	CbGpPWpGaD
Zopiclone—PTGS1—Biological oxidations—CYP24A1—multiple sclerosis	1.67e-05	0.00819	CbGpPWpGaD
Zopiclone—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	1.65e-05	0.0081	CbGpPWpGaD
Zopiclone—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	1.65e-05	0.0081	CbGpPWpGaD
Zopiclone—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	1.49e-05	0.00732	CbGpPWpGaD
Zopiclone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	1.35e-05	0.00659	CbGpPWpGaD
Zopiclone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	1.35e-05	0.00659	CbGpPWpGaD
Zopiclone—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	1.33e-05	0.00651	CbGpPWpGaD
Zopiclone—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	1.33e-05	0.00651	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	1.31e-05	0.0064	CbGpPWpGaD
Zopiclone—CYP2E1—Biological oxidations—CYP27B1—multiple sclerosis	1.25e-05	0.00612	CbGpPWpGaD
Zopiclone—CYP2E1—Biological oxidations—CYP24A1—multiple sclerosis	1.25e-05	0.00612	CbGpPWpGaD
Zopiclone—CYP2E1—Metapathway biotransformation—CYP27B1—multiple sclerosis	1.23e-05	0.00604	CbGpPWpGaD
Zopiclone—CYP2E1—Metapathway biotransformation—CYP24A1—multiple sclerosis	1.23e-05	0.00604	CbGpPWpGaD
Zopiclone—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	1.21e-05	0.00592	CbGpPWpGaD
Zopiclone—PTGS1—Overview of nanoparticle effects—TNF—multiple sclerosis	1.18e-05	0.00578	CbGpPWpGaD
Zopiclone—GABRG3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	1.09e-05	0.00536	CbGpPWpGaD
Zopiclone—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	1.09e-05	0.00534	CbGpPWpGaD
Zopiclone—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	1.09e-05	0.00534	CbGpPWpGaD
Zopiclone—CYP2C8—Biological oxidations—CYP27B1—multiple sclerosis	1.08e-05	0.00529	CbGpPWpGaD
Zopiclone—CYP2C8—Biological oxidations—CYP24A1—multiple sclerosis	1.08e-05	0.00529	CbGpPWpGaD
Zopiclone—GABRG3—Transmission across Chemical Synapses—BCHE—multiple sclerosis	1.07e-05	0.00527	CbGpPWpGaD
Zopiclone—CYP2C8—Metapathway biotransformation—CYP27B1—multiple sclerosis	1.06e-05	0.00522	CbGpPWpGaD
Zopiclone—CYP2C8—Metapathway biotransformation—CYP24A1—multiple sclerosis	1.06e-05	0.00522	CbGpPWpGaD
Zopiclone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	1.05e-05	0.00515	CbGpPWpGaD
Zopiclone—GABRB3—BDNF signaling pathway—CNR1—multiple sclerosis	1.04e-05	0.00509	CbGpPWpGaD
Zopiclone—PTGS1—Overview of nanoparticle effects—IL6—multiple sclerosis	9.52e-06	0.00466	CbGpPWpGaD
Zopiclone—GABRB2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	9.21e-06	0.00451	CbGpPWpGaD
Zopiclone—GABRB2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	9.05e-06	0.00443	CbGpPWpGaD
Zopiclone—GABRA5—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	8.95e-06	0.00438	CbGpPWpGaD
Zopiclone—GABRA5—Transmission across Chemical Synapses—BCHE—multiple sclerosis	8.79e-06	0.00431	CbGpPWpGaD
Zopiclone—GABRA3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	8.78e-06	0.00431	CbGpPWpGaD
Zopiclone—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	8.78e-06	0.0043	CbGpPWpGaD
Zopiclone—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	8.78e-06	0.0043	CbGpPWpGaD
Zopiclone—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	8.66e-06	0.00425	CbGpPWpGaD
Zopiclone—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	8.66e-06	0.00425	CbGpPWpGaD
Zopiclone—GABRA2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	8.63e-06	0.00423	CbGpPWpGaD
Zopiclone—GABRA3—Transmission across Chemical Synapses—BCHE—multiple sclerosis	8.63e-06	0.00423	CbGpPWpGaD
Zopiclone—GABRB3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	8.58e-06	0.0042	CbGpPWpGaD
Zopiclone—GABRA2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	8.48e-06	0.00416	CbGpPWpGaD
Zopiclone—GABRB3—Transmission across Chemical Synapses—BCHE—multiple sclerosis	8.43e-06	0.00413	CbGpPWpGaD
Zopiclone—GABRG2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	8.42e-06	0.00413	CbGpPWpGaD
Zopiclone—GABRB3—BDNF signaling pathway—BDNF—multiple sclerosis	8.39e-06	0.00411	CbGpPWpGaD
Zopiclone—GABRG3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	8.29e-06	0.00406	CbGpPWpGaD
Zopiclone—GABRG2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	8.27e-06	0.00406	CbGpPWpGaD
Zopiclone—GABRG3—Neuronal System—BCHE—multiple sclerosis	8.23e-06	0.00404	CbGpPWpGaD
Zopiclone—GABRB3—BDNF signaling pathway—SPP1—multiple sclerosis	7.45e-06	0.00365	CbGpPWpGaD
Zopiclone—GABRA1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	7.36e-06	0.00361	CbGpPWpGaD
Zopiclone—GABRA1—Transmission across Chemical Synapses—BCHE—multiple sclerosis	7.23e-06	0.00354	CbGpPWpGaD
Zopiclone—PTGS1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.07e-06	0.00347	CbGpPWpGaD
Zopiclone—PTGS1—Selenium Micronutrient Network—ICAM1—multiple sclerosis	7.02e-06	0.00344	CbGpPWpGaD
Zopiclone—GABRB2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.98e-06	0.00342	CbGpPWpGaD
Zopiclone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	6.93e-06	0.0034	CbGpPWpGaD
Zopiclone—GABRB2—Neuronal System—BCHE—multiple sclerosis	6.93e-06	0.0034	CbGpPWpGaD
Zopiclone—GABRA5—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.78e-06	0.00332	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	6.76e-06	0.00331	CbGpPWpGaD
Zopiclone—GABRA5—Neuronal System—BCHE—multiple sclerosis	6.73e-06	0.0033	CbGpPWpGaD
Zopiclone—GABRA3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.66e-06	0.00326	CbGpPWpGaD
Zopiclone—GABRA3—Neuronal System—BCHE—multiple sclerosis	6.61e-06	0.00324	CbGpPWpGaD
Zopiclone—GABRG3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	6.55e-06	0.00321	CbGpPWpGaD
Zopiclone—GABRA2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.54e-06	0.00321	CbGpPWpGaD
Zopiclone—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.52e-06	0.0032	CbGpPWpGaD
Zopiclone—GABRB3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.5e-06	0.00319	CbGpPWpGaD
Zopiclone—GABRA2—Neuronal System—BCHE—multiple sclerosis	6.5e-06	0.00318	CbGpPWpGaD
Zopiclone—GABRB3—Neuronal System—BCHE—multiple sclerosis	6.46e-06	0.00316	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—IL10—multiple sclerosis	6.45e-06	0.00316	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	6.42e-06	0.00314	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	6.42e-06	0.00314	CbGpPWpGaD
Zopiclone—GABRG2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.38e-06	0.00313	CbGpPWpGaD
Zopiclone—GABRG2—Neuronal System—BCHE—multiple sclerosis	6.34e-06	0.00311	CbGpPWpGaD
Zopiclone—PTGS1—Selenium Micronutrient Network—CCL2—multiple sclerosis	6.29e-06	0.00308	CbGpPWpGaD
Zopiclone—PTGS1—Selenium Micronutrient Network—ALB—multiple sclerosis	5.86e-06	0.00287	CbGpPWpGaD
Zopiclone—GABRG3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.79e-06	0.00284	CbGpPWpGaD
Zopiclone—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	5.79e-06	0.00284	CbGpPWpGaD
Zopiclone—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	5.79e-06	0.00284	CbGpPWpGaD
Zopiclone—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	5.71e-06	0.0028	CbGpPWpGaD
Zopiclone—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	5.71e-06	0.0028	CbGpPWpGaD
Zopiclone—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.64e-06	0.00276	CbGpPWpGaD
Zopiclone—GABRA1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	5.58e-06	0.00273	CbGpPWpGaD
Zopiclone—GABRA1—Neuronal System—BCHE—multiple sclerosis	5.54e-06	0.00272	CbGpPWpGaD
Zopiclone—GABRB2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.52e-06	0.0027	CbGpPWpGaD
Zopiclone—GABRA5—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.36e-06	0.00263	CbGpPWpGaD
Zopiclone—PTGS1—Selenium Micronutrient Network—IFNG—multiple sclerosis	5.34e-06	0.00262	CbGpPWpGaD
Zopiclone—CYP2E1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.29e-06	0.00259	CbGpPWpGaD
Zopiclone—GABRA3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.26e-06	0.00258	CbGpPWpGaD
Zopiclone—GABRA2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.17e-06	0.00253	CbGpPWpGaD
Zopiclone—GABRB3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.14e-06	0.00252	CbGpPWpGaD
Zopiclone—GABRG2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.05e-06	0.00247	CbGpPWpGaD
Zopiclone—GABRB2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.88e-06	0.00239	CbGpPWpGaD
Zopiclone—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—multiple sclerosis	4.81e-06	0.00236	CbGpPWpGaD
Zopiclone—PTGS1—Selenium Micronutrient Network—IL1B—multiple sclerosis	4.77e-06	0.00234	CbGpPWpGaD
Zopiclone—GABRA5—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.74e-06	0.00232	CbGpPWpGaD
Zopiclone—GABRA3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.65e-06	0.00228	CbGpPWpGaD
Zopiclone—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.59e-06	0.00225	CbGpPWpGaD
Zopiclone—GABRA2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.57e-06	0.00224	CbGpPWpGaD
Zopiclone—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.57e-06	0.00224	CbGpPWpGaD
Zopiclone—GABRB3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.54e-06	0.00223	CbGpPWpGaD
Zopiclone—GABRG2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.46e-06	0.00219	CbGpPWpGaD
Zopiclone—GABRA1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.41e-06	0.00216	CbGpPWpGaD
Zopiclone—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	4.18e-06	0.00205	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.14e-06	0.00203	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.14e-06	0.00203	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—SRM—multiple sclerosis	4.06e-06	0.00199	CbGpPWpGaD
Zopiclone—GABRA1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.9e-06	0.00191	CbGpPWpGaD
Zopiclone—PTGS1—Biological oxidations—POMC—multiple sclerosis	3.76e-06	0.00184	CbGpPWpGaD
Zopiclone—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.72e-06	0.00182	CbGpPWpGaD
Zopiclone—GABRB3—BDNF signaling pathway—STAT3—multiple sclerosis	3.52e-06	0.00173	CbGpPWpGaD
Zopiclone—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	3.52e-06	0.00172	CbGpPWpGaD
Zopiclone—PTGS1—Selenium Micronutrient Network—TNF—multiple sclerosis	3.46e-06	0.0017	CbGpPWpGaD
Zopiclone—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	3.42e-06	0.00167	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	3.38e-06	0.00166	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.37e-06	0.00165	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.37e-06	0.00165	CbGpPWpGaD
Zopiclone—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	3.35e-06	0.00164	CbGpPWpGaD
Zopiclone—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	3.3e-06	0.00162	CbGpPWpGaD
Zopiclone—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	3.28e-06	0.00161	CbGpPWpGaD
Zopiclone—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	3.22e-06	0.00158	CbGpPWpGaD
Zopiclone—GABRB3—BDNF signaling pathway—MAPK1—multiple sclerosis	3.2e-06	0.00157	CbGpPWpGaD
Zopiclone—GABRG3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	3.14e-06	0.00154	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—SRM—multiple sclerosis	3.03e-06	0.00149	CbGpPWpGaD
Zopiclone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.03e-06	0.00148	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—CYP24A1—multiple sclerosis	2.86e-06	0.0014	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—CYP27B1—multiple sclerosis	2.86e-06	0.0014	CbGpPWpGaD
Zopiclone—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	2.81e-06	0.00138	CbGpPWpGaD
Zopiclone—CYP2E1—Biological oxidations—POMC—multiple sclerosis	2.81e-06	0.00138	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.79e-06	0.00137	CbGpPWpGaD
Zopiclone—PTGS1—Selenium Micronutrient Network—IL6—multiple sclerosis	2.79e-06	0.00137	CbGpPWpGaD
Zopiclone—GABRB2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.64e-06	0.0013	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—SRM—multiple sclerosis	2.62e-06	0.00128	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—GPC5—multiple sclerosis	2.61e-06	0.00128	CbGpPWpGaD
Zopiclone—GABRA5—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.57e-06	0.00126	CbGpPWpGaD
Zopiclone—GABRA3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.52e-06	0.00124	CbGpPWpGaD
Zopiclone—GABRA2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.48e-06	0.00121	CbGpPWpGaD
Zopiclone—GABRB3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.46e-06	0.00121	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	2.45e-06	0.0012	CbGpPWpGaD
Zopiclone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.45e-06	0.0012	CbGpPWpGaD
Zopiclone—CYP2C8—Biological oxidations—POMC—multiple sclerosis	2.43e-06	0.00119	CbGpPWpGaD
Zopiclone—GABRG2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.42e-06	0.00119	CbGpPWpGaD
Zopiclone—GABRG3—Neuronal System—MAPK1—multiple sclerosis	2.41e-06	0.00118	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—RRM1—multiple sclerosis	2.17e-06	0.00106	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—CYP27B1—multiple sclerosis	2.14e-06	0.00105	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—CYP24A1—multiple sclerosis	2.14e-06	0.00105	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—SRM—multiple sclerosis	2.13e-06	0.00104	CbGpPWpGaD
Zopiclone—GABRA1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.11e-06	0.00104	CbGpPWpGaD
Zopiclone—GABRG3—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.09e-06	0.00102	CbGpPWpGaD
Zopiclone—GABRB2—Neuronal System—MAPK1—multiple sclerosis	2.03e-06	0.000993	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	1.98e-06	0.000971	CbGpPWpGaD
Zopiclone—CYP2C9—Biological oxidations—POMC—multiple sclerosis	1.98e-06	0.000968	CbGpPWpGaD
Zopiclone—GABRA5—Neuronal System—MAPK1—multiple sclerosis	1.97e-06	0.000964	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—GPC5—multiple sclerosis	1.95e-06	0.000957	CbGpPWpGaD
Zopiclone—GABRA3—Neuronal System—MAPK1—multiple sclerosis	1.93e-06	0.000947	CbGpPWpGaD
Zopiclone—GABRA2—Neuronal System—MAPK1—multiple sclerosis	1.9e-06	0.000931	CbGpPWpGaD
Zopiclone—GABRB3—Neuronal System—MAPK1—multiple sclerosis	1.89e-06	0.000925	CbGpPWpGaD
Zopiclone—GABRG2—Neuronal System—MAPK1—multiple sclerosis	1.85e-06	0.000908	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	1.85e-06	0.000905	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	1.85e-06	0.000905	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.8e-06	0.000884	CbGpPWpGaD
Zopiclone—GABRB2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.76e-06	0.000861	CbGpPWpGaD
Zopiclone—GABRA5—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.71e-06	0.000836	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—GPC5—multiple sclerosis	1.69e-06	0.000827	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.68e-06	0.000823	CbGpPWpGaD
Zopiclone—GABRA3—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.67e-06	0.000821	CbGpPWpGaD
Zopiclone—GABRA2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.65e-06	0.000807	CbGpPWpGaD
Zopiclone—GABRB3—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.64e-06	0.000802	CbGpPWpGaD
Zopiclone—GABRA1—Neuronal System—MAPK1—multiple sclerosis	1.62e-06	0.000794	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—RRM1—multiple sclerosis	1.62e-06	0.000793	CbGpPWpGaD
Zopiclone—GABRG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.61e-06	0.000787	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	1.5e-06	0.000736	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	1.5e-06	0.000736	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.47e-06	0.00072	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.44e-06	0.000707	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—SRM—multiple sclerosis	1.41e-06	0.000689	CbGpPWpGaD
Zopiclone—GABRA1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.4e-06	0.000688	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—RRM1—multiple sclerosis	1.4e-06	0.000686	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GPC5—multiple sclerosis	1.37e-06	0.000673	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.32e-06	0.000645	CbGpPWpGaD
Zopiclone—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.3e-06	0.000639	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—BCHE—multiple sclerosis	1.24e-06	0.00061	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.14e-06	0.000558	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.09e-06	0.000532	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	9.91e-07	0.000486	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	9.91e-07	0.000486	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	9.32e-07	0.000457	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—BCHE—multiple sclerosis	9.29e-07	0.000456	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GPC5—multiple sclerosis	9.06e-07	0.000444	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.83e-07	0.000433	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.5e-07	0.000417	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—BCHE—multiple sclerosis	8.03e-07	0.000394	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.59e-07	0.000372	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—RRM1—multiple sclerosis	7.51e-07	0.000368	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—APOE—multiple sclerosis	7.48e-07	0.000367	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.92e-07	0.000339	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—BCHE—multiple sclerosis	6.54e-07	0.00032	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—POMC—multiple sclerosis	6.43e-07	0.000315	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—ALB—multiple sclerosis	5.86e-07	0.000287	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—APOE—multiple sclerosis	5.59e-07	0.000274	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—APOE—multiple sclerosis	4.83e-07	0.000237	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—POMC—multiple sclerosis	4.8e-07	0.000235	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—ALB—multiple sclerosis	4.38e-07	0.000215	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—BCHE—multiple sclerosis	4.31e-07	0.000211	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—POMC—multiple sclerosis	4.15e-07	0.000203	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—APOE—multiple sclerosis	3.93e-07	0.000193	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—ALB—multiple sclerosis	3.78e-07	0.000186	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—POMC—multiple sclerosis	3.38e-07	0.000166	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—ALB—multiple sclerosis	3.08e-07	0.000151	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—APOE—multiple sclerosis	2.59e-07	0.000127	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—POMC—multiple sclerosis	2.23e-07	0.000109	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—ALB—multiple sclerosis	2.03e-07	9.96e-05	CbGpPWpGaD
